Loading...
Futura Medical plc
FAMDF•PNK
HealthcareBiotechnology
$0.10
$0.005(5.26%)
Futura Medical plc (FAMDF) Stock Overview
Explore Futura Medical plc’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for FAMDFStats details for FAMDF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for FAMDFAnalyst Recommendations details for FAMDF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. The company was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
CEO
Mr. James Henry Barder
Employees
14
Headquarters
Surrey Technology Centre, Guildford
Founded
2012